share_log

S-3: Registration statement for specified transactions by certain issuers

S-3: Registration statement for specified transactions by certain issuers

S-3：特定交易注册声明
美股SEC公告 ·  08/02 16:10

Moomoo AI 已提取核心信息

SeaStar Medical Holding Corporation, a Delaware-based company, has filed a registration statement with the Securities and Exchange Commission (SEC) on August 2, 2024, for a Form S-3 registration. This filing pertains to the potential sale of up to 1,014,219 shares of common stock by certain selling securityholders. These shares are issuable upon the exercise of previously issued warrants. The registration allows these securityholders to resell their shares in the public market. SeaStar Medical will not receive any proceeds from the sale of these shares, but will receive the exercise price of the warrants unless they are exercised on a cashless basis. The company will bear all expenses related to the registration of the shares. The selling securityholders may sell their shares through various methods including on exchanges, in the over-the-counter market, or through private transactions. The registration statement also includes indemnification agreements for directors and officers, and details on the legal and accounting costs associated with the registration.
SeaStar Medical Holding Corporation, a Delaware-based company, has filed a registration statement with the Securities and Exchange Commission (SEC) on August 2, 2024, for a Form S-3 registration. This filing pertains to the potential sale of up to 1,014,219 shares of common stock by certain selling securityholders. These shares are issuable upon the exercise of previously issued warrants. The registration allows these securityholders to resell their shares in the public market. SeaStar Medical will not receive any proceeds from the sale of these shares, but will receive the exercise price of the warrants unless they are exercised on a cashless basis. The company will bear all expenses related to the registration of the shares. The selling securityholders may sell their shares through various methods including on exchanges, in the over-the-counter market, or through private transactions. The registration statement also includes indemnification agreements for directors and officers, and details on the legal and accounting costs associated with the registration.
总部位于特拉华州的SeaStar Medical Holding Corporation已于2024年8月2日向美国证券交易委员会（SEC）提交了S-3表格的注册声明。此文件与特定售出证券持有人可能出售的最多1,014,219股普通股有关。这些股票可在行使之前发行的认股权行权后发放。注册声明允许这些证券持有人在公开市场上转售他们的股票。SeaStar Medical将不会从这些股票的出售中获得任何收益，除非这些认股权在无现金基础下行使。公司将承担与股票注册相关的所有费用。售出证券持有人可以通过各种方法出售他们的股票，包括在交易所、场外市场或私人交易中出售。注册声明还包括董事和高管的赔偿协议以及与注册相关的法律和会计成本的详细信息。
总部位于特拉华州的SeaStar Medical Holding Corporation已于2024年8月2日向美国证券交易委员会（SEC）提交了S-3表格的注册声明。此文件与特定售出证券持有人可能出售的最多1,014,219股普通股有关。这些股票可在行使之前发行的认股权行权后发放。注册声明允许这些证券持有人在公开市场上转售他们的股票。SeaStar Medical将不会从这些股票的出售中获得任何收益，除非这些认股权在无现金基础下行使。公司将承担与股票注册相关的所有费用。售出证券持有人可以通过各种方法出售他们的股票，包括在交易所、场外市场或私人交易中出售。注册声明还包括董事和高管的赔偿协议以及与注册相关的法律和会计成本的详细信息。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间